Southern California Research Center for ALPD and Cirrhosis, Department of Pathology, Keck School of Medicine of the University of Southern California, USA.
Southern California Research Center for ALPD and Cirrhosis, Department of Pathology, Keck School of Medicine of the University of Southern California, USA.
J Hepatol. 2011 Sep;55(3):673-682. doi: 10.1016/j.jhep.2010.12.034. Epub 2011 Jan 21.
BACKGROUND & AIMS: Mechanisms underlying synergistic liver injury caused by alcohol and obesity are not clear. We have produced a mouse model of synergistic steatohepatitis by recapitulating the natural history of the synergism seen in patients for mechanistic studies.
Moderate obesity was induced in mice by 170% overnutrition in calories using intragastric overfeeding of high fat diet. Alcohol (low or high dose) was then co-administrated to determine its effects.
Moderate obesity plus alcohol intake causes synergistic steatohepatitis in an alcohol dose-dependent manner. A heightened synergism is observed when a high alcohol dose (32g/kg/d) is used, resulting in plasma ALT reaching 392±28U/L, severe steatohepatitis with pericellular fibrosis, marked M1 macrophage activation, a 40-fold induction of iNos, and intensified nitrosative stress in the liver. Hepatic expression of genes for mitochondrial biogenesis and metabolism are significantly downregulated, and hepatic ATP level is decreased. Synergistic ER stress evident by elevated XBP-1, GRP78 and CHOP is accompanied by hyperhomocysteinemia. Despite increased caspase 3/7 cleavage, their activities are decreased in a redox-dependent manner. Neither increased PARP cleavage nor TUNEL positive hepatocytes are found, suggesting a shift of apoptosis to necrosis. Surprisingly, the synergism mice have increased plasma adiponectin and hepatic p-AMPK, but adiponectin resistance is shown downstream of p-AMPK.
Nitrosative stress mediated by M1 macrophage activation, adiponectin resistance, and accentuated ER and mitochondrial stress underlie potential mechanisms for synergistic steatohepatitis caused by moderate obesity and alcohol.
酒精和肥胖协同导致肝损伤的机制尚不清楚。我们通过重现患者中观察到的协同作用的自然史,构建了协同性脂肪性肝炎的小鼠模型,用于进行机制研究。
通过胃内给予高脂肪饮食过量喂养,使小鼠产生适度肥胖,热量摄入增加 170%。然后共同给予酒精(低剂量或高剂量)以确定其作用。
适度肥胖加上酒精摄入以酒精剂量依赖的方式导致协同性脂肪性肝炎。当使用高酒精剂量(32g/kg/d)时,观察到协同作用增强,导致血浆 ALT 达到 392±28U/L,严重脂肪性肝炎伴细胞周纤维化,M1 巨噬细胞明显激活,iNos 诱导增加 40 倍,肝脏中硝态应激加剧。肝脏中线粒体生物发生和代谢的基因表达显著下调,肝内 ATP 水平降低。协同性内质网应激通过升高 XBP-1、GRP78 和 CHOP 表现出来,同时伴有高同型半胱氨酸血症。尽管 caspase 3/7 裂解增加,但它们的活性以依赖于氧化还原的方式降低。未发现增加的 PARP 裂解或 TUNEL 阳性肝细胞,表明凋亡向坏死转移。令人惊讶的是,协同性肥胖的小鼠有增加的血浆脂联素和肝脏 p-AMPK,但脂联素抵抗表现为 p-AMPK 下游。
M1 巨噬细胞激活介导的硝化应激、脂联素抵抗以及内质网和线粒体应激的加剧,可能是由适度肥胖和酒精引起的协同性脂肪性肝炎的潜在机制。